Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic v. Boston Scientific: Appeals Court Affirms Taxus Non-Infringement

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific's Taxus, Express and NIR stents do not infringe four Medtronic stent design patents, the U.S. Court of Appeals for the Federal Circuit affirms in a May 26 ruling

You may also be interested in...

Medtronic Stent Patent Ruling Makes DES Vulnerable; Will Guidant Cut Deal?

Medtronic will appeal a Delaware federal court patent infringement ruling against its Driver and S7 coronary stents and challenge the validity of Guidant's Lau patent, the firm says

Biogen Doubles Down On Alzheimer’s and Neuroscience With Sangamo Gene Regulation Deal

As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.

C-Suite Snippets: Growth Of A Cell And Gene Powerhouse

In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts